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ABSTRACT
Background and Objectives: Conflicting data exist regarding the prognostic implication of 
ventricular conduction disturbance pattern in patients with heart failure (HF). This study 
investigated the prognostic impact of ventricular conduction pattern in hospitalized patients 
with acute HF.
Methods: Data from the Korean Acute Heart Failure registry were used. Patients were 
categorized into four groups: narrow QRS (<120 ms), right bundle branch block (RBBB), left 
bundle branch block (LBBB), and nonspecific intraventricular conduction delay (NICD). The 
NICD was defined as prolonged QRS (≥120 ms) without typical features of LBBB or RBBB. 
The primary endpoint was the composite of all-cause mortality or rehospitalization for HF 
aggravation within 1 year after discharge.
Results: This study included 5,157 patients. The primary endpoint occurred in 39.7% of study 
population. The LBBB group showed the highest incidence of primary endpoint followed by 
NICD, RBBB, and narrow QRS groups (52.5% vs. 49.7% vs. 44.4% vs. 37.5%, p<0.001). In a 
multivariable Cox-proportional hazards regression analysis, LBBB and NICD were associated 
with 39% and 28% increased risk for primary endpoint (LBBB hazard ratio [HR], 1.392; 95% 
confidence interval [CI], 1.152–1.681; NICD HR, 1.278; 95% CI, 1.074–1.520) compared with 
narrow QRS group. The HR of RBBB for the primary endpoint was 1.103 (95% CI, 0.915–1.329).
Conclusions: LBBB and NICD were independently associated with an increased risk of 1-year 
adverse event in hospitalized patients with HF, whereas the prognostic impacts of RBBB 
were limited.
Trial Registration: ClinicalTrials.gov Identifier: NCT01389843
Keywords: Cardiac conduction system disease; Bundle branch block; Prognosis; Heart failure
Korean Circ J. 2019 Jul;49(7):602-611
https://doi.org/10.4070/kcj.2018.0290
pISSN 1738-5520·eISSN 1738-5555
Original Article
Received: Aug 27, 2018
Revised: Dec 3, 2018
Accepted: Jan 23, 2019
Correspondence to
Dong-Ju Choi, MD, PhD
Department of Cardiology, Cardiovascular 
Center, Seoul National University Bundang 
Hospital, 82, Gumi-ro 173beon-gil, Seongnam 
13620, Korea.
E-mail: djchoi@snubh.org
Copyright © 2019. The Korean Society of 
Cardiology
This is an Open Access article distributed 
under the terms of the Creative Commons 
Attribution Non-Commercial License (https://
creativecommons.org/licenses/by-nc/4.0) 
which permits unrestricted noncommercial 
use, distribution, and reproduction in any 
medium, provided the original work is properly 
cited.
ORCID iDs
Ji Hyun Lee 
https://orcid.org/0000-0002-7162-1248
Jin Joo Park 
https://orcid.org/0000-0001-9611-1490
Youngjin Cho 
https://orcid.org/0000-0001-8106-3713
Ji Hyun Lee , MD1, Jin Joo Park , MD2, Youngjin Cho , MD2, Il-Young Oh , MD2, 
Byung-Su Yoo , MD1, Jae-Joong Kim , MD3, Kye Hun Kim , MD4,  
Seok-Min Kang , MD5, Sang Hong Baek , MD6, Eun-Seok Jeon , MD7,  
Myeong-Chan Cho , MD8, Shung Chull Chae , MD9, Byung-Hee Oh , MD10, and 
Dong-Ju Choi , MD, PhD2
1Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea
2 Department of Cardiology, Cardiovascular Center, Seoul National University Bundang Hospital, Seongnam, 
Korea
3Division of Cardiology, Heart Institute, Asan Medical Center, University of Ulsan, Seoul, Korea
4Department of Internal Medicine, Heart Research Center of Chonnam National University, Gwangju, Korea
5Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea
6Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea
7Department of Internal Medicine, Sungkyunkwan University College of Medicine, Seoul, Korea
8Department of Internal Medicine, Chungbuk National University College of Medicine, Cheongju, Korea
9Department of Internal Medicine, Kyungpook National University College of Medicine, Daegu, Korea
10Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea
Prognostic Implication of Ventricular 
Conduction Disturbance Pattern in 
Hospitalized Patients with Acute 
Heart Failure Syndrome
Il-Young Oh 
https://orcid.org/0000-0002-5584-605X
Byung-Su Yoo 
https://orcid.org/0000-0002-3395-4279
Jae-Joong Kim 
https://orcid.org/0000-0002-2714-2282
Kye Hun Kim 
https://orcid.org/0000-0002-6885-1501
Seok-Min Kang 
https://orcid.org/0000-0001-9856-9227
Sang Hong Baek 
https://orcid.org/0000-0002-7065-3432
Eun-Seok Jeon 
https://orcid.org/0000-0002-9946-5611
Myeong-Chan Cho 
https://orcid.org/0000-0002-0047-0227
Shung Chull Chae 
https://orcid.org/0000-0002-9871-6976
Byung-Hee Oh 
https://orcid.org/0000-0002-9945-4306
Dong-Ju Choi 
https://orcid.org/0000-0003-0146-2189
Trial Registration
ClinicalTrials.gov Identifier: NCT01389843
Funding
This work was supported by the Research 
of Korea Centers for Disease Control and 
Prevention (2010-E63003-00, 2011-E63002-
00, 2012-E63005-00, 2013-E63003-00, 
2013-E63003-01, 2013-E63003-02, and 2016-
ER6303-00).
Conflict of Interest
The authors have no financial conflicts of 
interest.
Author Contributions
Conceptualization: Choi DJ, Lee JH, Park 
JJ, Cho Y, Oh IY; Data curation: Lee JH; 
Methodology: Choi DJ, Lee JH, Park JJ; 
Supervision: Choi DJ, Yoo BS, Kim JJ, Kim KH, 
Kang SM, Baek SH, Jeon ES, Cho MC, Chae SC, 
Oh BH; Validation: Lee JH; Visualization: Lee 
JH, Cho Y, Oh IY; Writing - original draft: Lee 
JH; Writing - review & editing: Choi DJ, Lee JH, 
Park JJ, Cho Y, Oh IY.
INTRODUCTION
Increased QRS width has been known to be associated with poor prognosis in patients 
with heart failure (HF).1) However, despite the similar degree of QRS prolongation, their 
prognosis might be different according to the patterns of ventricular conduction disturbance. 
Previously, the prognostic impact between left bundle branch block (LBBB) and right bundle 
branch block (RBBB) has been compared in patients with HF. However, the results were 
inconsistent and remain controversial until now.2-5)
Nonspecific intraventricular conduction delay (NICD) generally refers to QRS prolongation 
without a typical RBBB or LBBB pattern.6) The prevalence of NICD was reported in 3.8–5.8% 
of HF patients with reduced ejection fraction.6) Despite its considerable prevalence, the 
prognostic impact of NICD in patients with HF has not been well evaluated and compared 
with that of typical bundle branch blocks (BBBs), especially in East Asia. Therefore, we 
sought to investigate the prognostic impact of NICD and to compare that with those of 
narrow QRS, RBBB and LBBB in hospitalized patients with acute HF.
METHODS
Study population
We used data from the Korean Acute Heart Failure (KorAHF) registry, a prospective 
multicenter cohort study that consecutively enrolled 5,625 patients who were hospitalized 
for acute HF syndrome from 10 tertiary university hospitals throughout the country 
between March 2011 and December 2014. Detailed information on the study design and 
results has been previously reported elsewhere (ClinicalTrial.gov NCT01389843).7)8) In brief, 
patients with signs or symptoms of HF and either lung congestion, objective findings of 
left ventricular systolic dysfunction, or structural heart disease were eligible for the study. 
The mortality data for patients who were lost to follow-up were collected from the National 
Insurance data or National Death Records.
All patients with available baseline electrocardiography (ECG) data in the KorAHF registry 
were included in the present study. We excluded patients with a pacing rhythm (those with 
a permanent pacemaker or receiving cardiac resynchronization therapy [CRT]), ventricular 
rhythm, or pre-excitation, and patients who died or underwent urgent heart transplantation 
during initial hospitalization.
The study protocol was approved by the ethics committee or institutional review board at 
each hospital. The need for written informed consent was waived by the institutional review 
board. The study complied with the Declaration of Helsinki.
Study variables
Patients were categorized into four groups: narrow QRS (<120 ms), RBBB, LBBB, and NICD. 
The World Health Organization's criteria were used to define NICD, RBBB, and LBBB.9) 
NICD was defined as prolonged QRS (≥120 ms) without typical features of LBBB or RBBB.9) 
Standard 12-lead ECG was performed with the subject at rest using a paper speed of 25 
mm/s and a calibration of 1 mV per 10 mm. Each electrocardiogram was reviewed by two 
independent cardiologists. The primary endpoint was the composite of all-cause mortality or 
rehospitalization for HF aggravation within 1 year after discharge.
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Statistical analysis
Categorical variables are presented as numbers and frequencies, whereas continuous variables 
are presented as mean±standard deviation. Student's t-test or analysis of variance was used to 
compare continuous variables, and the χ2 test was used to compare categorical variables.
Kaplan-Meier curves were plotted and compared using the log-rank test. To adjust for 
covariates, a multivariable Cox proportional hazards regression model was used to predict 
the primary endpoint. Age, sex, body mass index, de novo HF, ischemic etiology, presence 
of hypertension, presence of diabetes mellitus, left ventricular ejection fraction (LVEF), 
presence of atrial fibrillation, serum hemoglobin level, serum creatinine level, high-sensitivity 
C-reactive protein level, beta-blocker use, renin-angiotensin-system  
inhibitor use, and mineralocorticoid receptor antagonist use were included in the 
multivariable model. Statistical tests were performed using SPSS, version 22 (IBM Corp., 
Armonk, NY, USA) and R programming version 3.5.1 (http://www.R-project.org; R 
Foundation for Statistical Computing, Vienna, Austria).
RESULTS
Study population
This study included 5,157 patients for the analysis. The flow chart of patient selection is 
depicted in Figure 1. The patients with narrow QRS accounted for 80.2% (n=4,136) of the 
total subjects, followed by NICD (7.4%, n=378), RBBB (7.0%, n=363), and LBBB (5.4%, 
n=280). Baseline characteristics of the study population were significantly different among 
the groups (Table 1). The patients with LBBB were the oldest (73.0±11.1 years), followed by 
those with RBBB (69.0±14.2 years), narrow QRS (68.3±14.8 years), and NICD (66.0±13.5 
years, p<0.001). The LVEF was the lowest in patients with NICD (28.6±13.4%), followed by 
those with LBBB (29.7±12.4%), narrow QRS (40.1±15.6%), and RBBB (40.7±16.7%, p<0.01). 
The QRS width was the largest in patients with LBBB (155.8±19.1 ms), followed by those with 
RBBB (147.0±19.6 ms), NICD (138.8±24.1 ms), and narrow QRS (93.6±12.1 ms).
Clinical outcomes
During the 1-year follow-up, primary endpoint occurred in 2,045 (39.7%) patients (All-cause 
death: 939, HF rehospitalization: 1,421). The incidence of the primary endpoint was the 
highest in patients with LBBB (n=147, 52.5%), followed by those with NICD (n=188, 49.7%), 
RBBB (n=161, 44.4%), and narrow QRS (n=1,549, 37.5%) (Table 2). All-cause mortality was 
the highest in NICD group (n=96, 25.4%) followed by LBBB (n=61, 21.8%), RBBB (n=77, 
21.2%) and narrow QRS (n=705, 17%, p<0.001) while the rehospitalization rate was the 
highest in LBBB group (n=111, 39.6%) followed by NICD (n=127, 33.6%), RBBB (n=117, 
32.2%) and narrow QRS (n=1,066, 25.8%, p<0.001).
In the Kaplan-Meier curve analysis, the RBBB, LBBB, and NICD groups showed a higher 
incidence of the primary composite endpoint than the narrow QRS group (p<0.001, Figure 2). 
The LBBB group showed the highest incidence of primary composite endpoints and HF 
rehospitalization, while NICD group showed the highest incidence of all-cause death among 
the study groups (Figure 2).
In the multivariable Cox-proportional hazard regression analysis, LBBB and NICD were 
associated with 39% and 28% increased risk for primary endpoint (LBBB hazard ratio [HR], 
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1.392, 95% confidence interval [CI], 1.152–1.681; NICD HR, 1.278; 95% CI, 1.074–1.520) 
compared with the narrow QRS group, while RBBB showed modest association with the 
primary endpoint (HR, 1.103; 95% CI, 0.915–1.329; Table 3).
In the subgroup analysis, similar trends of worse outcome with LBBB and NICD were 
observed consistently regardless of age (age <75 years vs. age ≥75 years), sex, LVEF (LVEF 
≤40% vs. LVEF ≥50%), HF etiology (ischemic vs. non-ischemic) and presence of renal 
dysfunction (Figure 3).
DISCUSSION
The present study demonstrated the prognostic impacts of different left ventricular 
conduction disturbances in patients with HF. Patients with LBBB and NICD showed 
the worse prognosis compared with those with narrow QRS. This study finding implies 
that examining the patterns of ventricular conduction disturbance is important for risk 
stratification of patients with HF.
Chronic ventricular dyssynchrony and its consequent ventricular remodeling thought 
to be a main mechanism of LBBB to worsens the course of HF over time.4) However, 
the pathophysiology of NICD is complex. Possible mechanisms include atypical LBBB, 
intraventricular parietal block, and peri-infarct block. In contrast to LBBB, the left ventricular 
activation of NICD is relatively fast through the Purkinje network, but followed by slow 
activation in the scarred region.10) This unique activation pattern of NICD is attributed to 
the poor response to the CRT. The substrates of heterogeneous slow ventricular activation 
could also play a role in the development of ventricular arrhythmia in NICD. We think these 
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KorAHF registry
(n=5,625)
Analysis
(n=5,157)
Narrow QRS
QRS <120 ms
(n=4,136)
RBBB
QRS ≥120 ms
(n=363)
LBBB
QRS ≥120 ms
(n=280)
NICD
QRS ≥120 ms without typical
LBBB or RBBB pattern
(n=378)
Exclusion
1.
2.
3.
4.
5.
6.
Not available ECG (n=32)
Patients with CRT (n=33)
Patients with permanent pacemaker (n=106)
Pre-excitation syndrome (n=1)
Ventricular rhythm: VT (n=20)
AIVR (n=2)
Ventricular escape (n=22)
In-hospital death or HTPL (n=252)
Figure 1. Flow chart of the patient selection. 
AIVR = accelerated idioventricular rhythm; CRT = cardiac resynchronization therapy; ECG = electrocardiography; HTPL = heart transplantation; KorAHF = Korean 
Acute Heart Failure; LBBB = left bundle branch block; NICD = nonspecific intraventricular conduction delay; RBBB = right bundle branch block; VT = ventricular 
tachycardia.
findings could partly explain the poor prognosis of the NICD group herein. The worse 
prognosis of NICD has been demonstrated previously in patients with structural heart 
disease and in a healthy population. According to Aro et al.'s study,11) patients with NICD 
were associated with a two-fold increased risk of all-cause death compared to those without 
NICD during a 30-year follow-up in a general population. Moreover, in the Multicenter 
Unsustained Tachycardia Trial, which enrolled patients with coronary artery disease, non-
sustained ventricular tachycardia, and depressed ejection fraction (LVEF ≤40%), patients 
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Table 1. Baseline characteristics of the study population
Variables Narrow QRS (n=4,136) RBBB (n=363) LBBB (n=280) NICD (n=378) p value
Age (years) 68.3±14.8 69.0±14.2 73.0±11.1 66.0±13.5 <0.001
Male 2,127 (51.4) 217 (59.8) 130 (46.4) 257 (68.0) <0.001
SBP at ADM (mmHg) 133.6±30.1 129.1±29.8 128.1±26.1 124.5±30.4 <0.001
DBP at ADM (mmHg) 80.1±18.8 76.2±17.1 75.0±15.8 77.0±18.6 <0.001
HR at ADM (bpm) 93.8±25.7 87.1±24.5 91.7±22.1 80.1±25.2 <0.001
BMI (kg/m2) 23.3±3.9 23.6±3.9 23.0±3.5 23.6±3.6 0.169
NYHA class IV 1,948 (47.1) 173 (47.7) 135 (48.2) 171 (45.2) 0.871
De novo HF 2,334 (56.4) 170 (46.8) 115 (41.1) 128 (33.9) <0.001
Ischemic HF 1,547 (37.4) 121 (33.3) 106 (37.9) 153 (40.5) 0.249
HFrEF (EF ≤40%) 2,138 (66.7) 187 (64.3) 230 (95.4) 296 (90.2) <0.001
Past history
Hypertension 2,469 (59.7) 202 (55.6) 165 (58.9) 211 (55.8) 0.253
DM type 2 1,430 (34.6) 123 (33.9) 118 (42.1) 151 (39.9) 0.014
MI 657 (15.9) 67 (18.5) 39 (13.9) 73 (19.3) 0.145
COPD 457 (11.1) 45 (12.4) 37 (13.2) 35 (9.3) 0.365
AF 1,181 (28.6) 132 (36.4) 52 (18.6) 101 (26.7) <0.001
CKD 566 (13.7) 52 (14.3) 42 (15.0) 53 (14.0) 0.923
LVEF (%) 40.1±15.6 40.7±16.7 29.7±12.4 28.6±13.4 <0.001
LVESD (mm) 43.8±11.6 43.5±12.4 52.5±10.7 55.2±12.6 <0.001
LVEDD (mm) 56.4±9.5 56.3±10.0 62.3±9.2 65.1±11.0 <0.001
Na (mmol/L) 137.8±4.6 137.1±5.2 137.5±4.7 136.4±5.3 0.008
HsCRP (mg/L) 2.2±4.1 2.5±4.9 1.9±3.1 2.4±4.3 0.277
Hb (g/dL) 12.4±2.3 12.6±2.3 12.3±2.0 12.7±2.4 0.065
Uric acid (mg/dL) 6.9±2.8 7.3±2.9 6.9±2.6 7.5±2.8 0.643
Albumin (g/dL) 3.7±0.5 3.7±0.5 3.8±0.5 3.7±0.5 0.060
Cr (mg/dL) 1.4±1.5 1.5±1.6 1.5±1.2 1.5±1.4 0.102
BNP (pg/mL) 858 (461, 1,704) 900 (441, 1,554) 1,023 (538, 2,145) 980 (539, 1,850) <0.001
NT-proBNP (pg/mL) 4,673 (2,024, 10,987) 5,515 (2,527, 12,780) 4,890 (2,560, 14,422) 4,790 (2,432, 12,333) <0.001
QRS width (ms) 93.6±12.1 147.0±19.6 155.8±19.1 138.8±24.1 <0.001
Discharge medication
Beta blocker 2,223 (53.7) 156 (43.0) 158 (56.4) 185 (48.9) <0.001
ACEi or ARB 2,834 (68.5) 232 (63.9) 215 (76.8) 277 (73.3) <0.001
MRA 1,867 (45.1) 179 (49.3) 152 (54.3) 207 (54.8) <0.001
Values are expressed as number (%) or mean±standard deviation or median (25th quartile, 75th quartile). 
ACEi = angiotensin-converting enzyme inhibitor; ADM = admission; AF = atrial fibrillation; ARB = angiotensin II receptor blocker; BMI = body mass index; BNP 
= brain natriuretic peptide; CKD = chronic kidney disease; COPD = chronic obstructive pulmonary disease; Cr = creatinine; DBP = diastolic blood pressure; DM 
= diabetes mellitus; EF = ejection fraction; Hb = hemoglobin; HF = heart failure; HFrEF = heart failure with reduced ejection fraction; HR = hazard ratio; HsCRP 
= high sensitivity C-reactive protein; LBBB = left bundle branch block; LVEF = left ventricular ejection fraction; LVEDD = left ventricular end-diastolic diameter; 
LVESD = left ventricular end-systolic diameter; MI = myocardial infarction; MRA = mineralocorticoid receptor antagonist; Na = sodium; NICD = nonspecific 
intraventricular conduction delay; NT-proBNP = N-terminal prohormone of brain natriuretic peptide; NYHA = New York Heart Association; RBBB = right bundle 
branch block; SBP = systolic blood pressure.
Table 2. Incidence of study endpoints according to the ventricular conduction patterns
Narrow QRS (n=4,136) RBBB (n=363) LBBB (n=280) NICD (n=378) p value
Primary endpoint 1,549 (37.5) 161 (44.4) 147 (52.5) 188 (49.7) <0.001
All cause death 705 (17.0) 77 (21.2) 61 (21.8) 96 (25.4) <0.001
Rehospitalization 1,066 (25.8) 117 (32.2) 111 (39.6) 127 (33.6) <0.001
Values are expressed as number (%). 
LBBB = left bundle branch block; NICD = nonspecific intraventricular conduction delay; RBBB = right bundle branch block.
with NICD were associated with a lower LVEF and 1.5-fold increased risk of all-cause 
mortality compared with those without NICD.12) We believe our results are consistent with the 
results of these previous studies.
There are controversies regarding the prognostic impact of the type of conduction 
disturbance in patients with HF. In a previous study, the presence of LBBB was independently 
associated with a 10% increased risk of mortality compared to those with narrow QRS (<120 ms) 
when 9,082 patients with HF were followed up over 5 years.4) In that study, RBBB showed 
modest prognostic implication (HR, 1.10; 95% CI, 0.99–1.21). However conflicting data also 
exists. Barsheshet et al.13) reported that the RBBB was associated with a 29% increased risk 
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No. at risk
Narrow QRS 4,136 3,053 2,632 2,392 2,194 2,002 1,827
RBBB 363 255 222 199 177 160 146
LBBB 280 191 159 139 125 112 100
NICD 378 255 215 187 167 147 132
No. at risk
Narrow QRS 4,136 3,016 2,593 2,368 2,178 1,991 1,828
RBBB 363 255 220 198 177 160 146
LBBB 280 187 156 136 125 111 100
NICD 378 252 212 186 166 146 132
No. at risk
Narrow QRS 4,136 3,901 3,755 3,659 3,573 3,500 3,435
RBBB 363 342 327 309 298 294 286
LBBB 280 255 245 239 230 223 220
NICD 378 350 331 312 299 289 282
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Figure 2. Kaplan-Meier curves for the incidence of study endpoints according to the different ventricular conduction patterns. 
LBBB = left bundle branch block; NICD = nonspecific intraventricular conduction delay; RBBB = right bundle branch block.
of all-cause death compared with LBBB in 1888 patients with systolic HF (ejection fraction 
<50%) followed over 4 years. Similarly, in the KorAHF registry, RBBB was associated with 
a 2.6-fold risk of all-cause death or re-hospitalization compared with LBBB.3) However, all 
these studies were performed after excluding patients with NICD. To date, relatively sparse 
data exist comparing the prognosis of NICD, RBBB, and LBBB in the same cohort. Tolppanen 
et al.5) followed up 982 patients with HF for 3.9 years and revealed that only presence of 
RBBB and NICD (QRS ≥110 ms) were associated with 1.7-fold and 1.6-fold increased risks of 
mortality respectively. Since the definition of NICD (QRS ≥110 ms) is different from that in 
our study (QRS ≥120 ms), these results cannot be directly compared with present study.
The prevalence of the pattern of conduction disturbance varies in HF patients with different 
ethnicities. According to the published data from Western countries, the prevalence of LBBB 
was reported to be 13–24% in patients with HF.4)14-17) Conversely, in Asia, the prevalence of 
LBBB was much lower (3.3–4.6%).3)18) According to the Spanish chronic HF registry, the 
prevalences of NICD, LBBB, and RBBB were reported as 5.8%, 23.6%, and 6%, respectively.17) 
In the present study, the prevalences of NICD, LBBB, and RBBB were 7.3%, 5.4%, and 7.0%, 
respectively. The contribution of ethnic differences on the pattern of conduction disturbance 
in HF is not yet completely understood.
QRS width was related to worse outcomes in previous studies of patients with HF.1)19)20) 
However, the variables of bundle branch blocks (BBBs) and NICD were not included in the 
multivariable analysis of these studies. Since the worse outcome of patients with NICD and 
BBBs automatically indicates the worse outcome of prolonged QRS, we believe our results are 
consistent with those of previous studies.
Present study has several limitations. First, there were significant differences in baseline 
characteristics between the study groups. Notably, the LBBB and NICD group had lower LVEF 
608https://e-kcj.org https://doi.org/10.4070/kcj.2018.0290
Conduction Disturbance in Heart Failure
Table 3. Cox hazard regression analysis for the primary endpoint
Variables Univariable analysis Multivariable analysis
HR (95% CI) p value HR (95% CI) p value
Age 1.022 (1.019–1.026) <0.001 1.017 (1.013–1.022) <0.001
Male 0.905 (0.830–0.987) 0.024 1.007 (0.906–1.118) 0.902
BMI (kg/m2) 0.958 (0.947–0.970) <0.001 0.983 (0.970–0.997) 0.018
De novo HF 0.599 (0.548–0.654) <0.001 0.755 (0.681–0.838) <0.001
Ischemic HF 1.297 (1.189–1.416) <0.001 1.110 (0.996–1.236) 0.058
LVEF (%) 0.997 (0.994–1.000) 0.029 0.994 (0.990–0.997) 0.001
Hypertension 1.356 (1.238–1.484) <0.001 1.126 (1.009–1.257) 0.034
DM 1.366 (1.251–1.492) <0.001 1.142 (1.028–1.268) 0.013
AF 1.233 (1.124–1.353) <0.001 1.114 (0.995–1.247) 0.060
Hb (g/dL) 0.885 (0.869–0.902) <0.001 0.932 (0.909–0.955) <0.001
Cr (mg/dL) 1.079 (1.056–1.103) <0.001 1.056 (1.023–1.090) 0.001
HsCRP (mg/dL) 1.019 (1.009–1.029) <0.001 1.011 (1.000–1.022) 0.055
Narrow QRS (<120 ms) 1 (Reference) NA 1 (Reference) NA
RBBB 1.237 (1.051–1.454) 0.010 1.103 (0.915–1.329) 0.304
LBBB 1.534 (1.295–1.816) <0.001 1.392 (1.152–1.681) 0.001
NICD 1.454 (1.250–1.692) <0.001 1.278 (1.074–1.520) 0.006
ACEi or ARB 0.772 (0.704–0.846) <0.001 0.829 (0.746–0.922) 0.001
BB 0.699 (0.641–0.763) <0.001 0.777 (0.704–0.857) <0.001
MRA 0.981 (0.899–1.070) 0.660 1.078 (0.976–1.191) 0.139
ACEi = angiotensin-converting enzyme inhibitor; AF = atrial fibrillation; ARB = angiotensin II receptor blocker; BB = beta blocker; BMI = body mass index; CI = 
confidence interval; Cr = creatinine; DM = diabetes mellitus; Hb = hemoglobin; HF = heart failure; HR = hazard ratio; HsCRP = high-sensitivity C-reactive protein; 
LBBB = left bundle branch block; LVEF = left ventricular ejection fraction; MRA = mineralocorticoid receptor antagonist; NA = not applicable; NICD = nonspecific 
intraventricular conduction delay; RBBB = right bundle branch block.
and higher left ventricular end-diastolic diameter compared to other groups at baseline. 
However, worse prognosis of LBBB and NICD were also observed in HF patients with 
preserved LVEF (LVEF ≥50%) in subgroup analysis. Nevertheless, potential confounders 
may still remain despite adjustments for the significant covariates in the multivariable 
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Conduction pattern No. Incidence HR (95% CI) p value Forest plot
Men (n=2,731)
Narrow QRS 2,127 756 (35.5) 1 (Reference) NA
RBBB 217 92 (42.4) 1.206 (0.971–1.497) 0.090
LBBB 130 75 (57.7) 1.829 (1.442–2.319) <0.001
NICD 257 120 (46.7) 1.384 (1.142–1.679) 0.001
Women (n=2,426)
Narrow QRS 2,009 793 (39.5) 1 (Reference) NA
RBBB 146 69 (47.3) 1.321 (1.033–1.689) 0.027
LBBB 150 72 (48.0) 1.292 (1.015–1.645) 0.037
NICD 121 68 (56.2) 1.717 (1.340–2.199) <0.001
Age <75 (n=3,129)
Narrow QRS 2,509 791 (31.5) 1 (Reference) NA
RBBB 216 88 (40.7) 1.418 (1.138–1.768) 0.002
LBBB 139 60 (43.2) 1.421 (1.093–1.847) 0.009
NICD 265 122 (46.0) 1.625 (1.343–1.967) <0.001
Age ≥75 (n=2,028)
Narrow QRS 1,627 758 (46.6) 1 (Reference) NA
RBBB 147 73 (49.7) 1.021 (0.803–1.299) 0.863
LBBB 141 87 (61.7) 1.506 (1.206–1.880) <0.001
NICD 113 66 (58.4) 1.363 (1.060–1.753) 0.016
EF ≤40 (n=2,851)
Narrow QRS 2,138 795 (37.2) 1 (Reference) NA
RBBB 187 88 (47.1) 1.407 (1.129–1.753) 0.002
LBBB 230 119 (51.7) 1.532 (1.264–1.858) <0.001
NICD 296 143 (48.3) 1.408 (1.178–1.682) <0.001
EF ≥50 (n=1,213)
Narrow QRS 1,066 398 (37.3) 1 (Reference) NA
RBBB 104 43 (41.3) 1.065 (0.778–1.459) 0.693
LBBB 11 7 (63.6) 2.239 (1.060–4.728) 0.035
NICD 32 17 (53.1) 1.751 (1.078–2.846) 0.024
Ischemic (n=1,927)
Narrow QRS 1,547 667 (43.1) 1 (Reference) NA
RBBB 121 60 (49.6) 1.174 (0.902–1.529) 0.234
LBBB 106 65 (61.3) 1.617 (1.253–2.086) <0.001
NICD 153 80 (52.3) 1.316 (1.043–1.659) 0.020
Non-ischemic (n=3,230)
Narrow QRS 2,589 882 (34.1) 1 (Reference) NA
RBBB 242 101 (41.7) 1.295 (1.054–1.592) 0.014
LBBB 174 82 (47.1) 1.481 (1.181–1.858) 0.001
NICD 225 108 (48.0) 1.551 (1.270–1.894) <0.001
CKD (n=713)
Narrow QRS 566 310 (54.8) 1 (Reference) NA
RBBB 52 27 (51.9) 0.958 (0.647–1.420) 0.832
LBBB 42 30 (71.4) 1.568 (1.077–2.281) 0.019
NICD 53 36 (67.9) 1.556 (1.102–2.198) 0.012
Non-CKD (n=4,444)
Narrow QRS 3,570 1,239 (34.7) 1 (Reference) NA
RBBB 311 134 (43.1) 1.300 (1.088–1.554) 0.004
LBBB 238 117 (49.2) 1.527 (1.263–1.845) <0.001
NICD 325 152 (46.8) 1.451 (1.226–1.717) <0.001
10.5 2
Figure 3. Subgroup analysis of the incidence of primary endpoint according to the different ventricular conduction patterns. 
CI = confidence interval; CKD = chronic kidney disease; EF = ejection fraction; HF = heart failure; HR = hazard ratio; HTN = hypertension; LBBB = left bundle 
branch block; NICD = nonspecific intraventricular conduction delay; RBBB = right bundle branch block.
model. Seconds, the prognostic implication of RBBB group might be underpowered to 
demonstrate statistical significance due to the small number of subjects. And the trends of 
worse prognosis in patients with RBBB might be clearer in a longer-term follow-up study. 
Third, the worse prognosis of LBBB group might be overestimated because we excluded the 
patients with CRT at baseline. Because we initially focused on the prognostic implication 
of the intrinsic LV conduction patterns, we had to exclude all patients with pacing rhythm. 
Fourth, we did not include implantable cardioverter defibrillator (ICD) and CRT implantation 
in the multivariable model. The benefits of an ICD and CRT were only limited to the eligible 
patients (LVEF ≤35%). Furthermore, we excluded patients with CRT at baseline as we 
mentioned above. Thus, we thought these variables were unsuitable for the multi-variable 
analysis in present study. Meanwhile, the ICD implantation rates during the follow up were 
1.4%, 4.1%, 5.4%, and 6.6% in the narrow QRS, RBBB, LBBB, and NICD groups. The CRT 
implantation rates during the follow-up were 0.2%, 1.1%, 5.0%, and 2.6% in the narrow 
QRS, RBBB, LBBB, and NICD groups, respectively.
In conclusion, LBBB and NICD was independently associated with an increased risk of all-cause 
mortality in hospitalized patients with acute HF syndrome. The prognostic impacts of RBBB 
were not very clear in this study. Further research is still required to assess the long-term 
prognosis according to the different conduction disturbance patterns.
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